Pan‐Woo Ko

567 total citations
22 papers, 371 citations indexed

About

Pan‐Woo Ko is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pan‐Woo Ko has authored 22 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 6 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pan‐Woo Ko's work include Cerebrospinal fluid and hydrocephalus (4 papers), Traumatic Brain Injury and Neurovascular Disturbances (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Pan‐Woo Ko is often cited by papers focused on Cerebrospinal fluid and hydrocephalus (4 papers), Traumatic Brain Injury and Neurovascular Disturbances (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Pan‐Woo Ko collaborates with scholars based in South Korea, United States and Canada. Pan‐Woo Ko's co-authors include Ho‐Won Lee, Kyunghun Kang, Kyoungho Suk, Jong‐Heon Kim, Ho‐Won Lee, Won‐Ha Lee, Ri Yu, Jiyoung Jeong, Jae‐Hong Kim and Won‐Jong Oh and has published in prestigious journals such as Neurology, Scientific Reports and IEEE Transactions on Biomedical Engineering.

In The Last Decade

Pan‐Woo Ko

18 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pan‐Woo Ko South Korea 10 157 109 101 50 43 22 371
Chiun-Chieh Yu Taiwan 10 165 1.1× 153 1.4× 20 0.2× 30 0.6× 62 1.4× 20 355
Wafa Regragui Morocco 11 442 2.8× 87 0.8× 114 1.1× 65 1.3× 93 2.2× 32 700
Michela Rosso United States 14 641 4.1× 257 2.4× 78 0.8× 66 1.3× 60 1.4× 36 798
Sheharyar Baig United Kingdom 10 92 0.6× 131 1.2× 145 1.4× 84 1.7× 33 0.8× 24 394
Valentina Nicoletti Italy 14 429 2.7× 157 1.4× 58 0.6× 95 1.9× 87 2.0× 21 717
Kyum‐Yil Kwon South Korea 18 473 3.0× 154 1.4× 70 0.7× 108 2.2× 51 1.2× 56 742
Babak Zamani Iran 12 261 1.7× 56 0.5× 65 0.6× 74 1.5× 45 1.0× 46 464
Fabin Lin China 12 110 0.7× 44 0.4× 24 0.2× 89 1.8× 67 1.6× 43 386
Shaobing Dai China 10 114 0.7× 151 1.4× 49 0.5× 47 0.9× 24 0.6× 20 319
Xiaowu Hu China 12 219 1.4× 126 1.2× 43 0.4× 73 1.5× 31 0.7× 32 422

Countries citing papers authored by Pan‐Woo Ko

Since Specialization
Citations

This map shows the geographic impact of Pan‐Woo Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan‐Woo Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan‐Woo Ko more than expected).

Fields of papers citing papers by Pan‐Woo Ko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pan‐Woo Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan‐Woo Ko. The network helps show where Pan‐Woo Ko may publish in the future.

Co-authorship network of co-authors of Pan‐Woo Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Pan‐Woo Ko. A scholar is included among the top collaborators of Pan‐Woo Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pan‐Woo Ko. Pan‐Woo Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ko, Pan‐Woo. (2024). Will ChatGPT be Useful for Korean Neurologists in Clinical Practice?. Journal of the Korean Neurological Association. 42(3). 233–240.
2.
Ko, Pan‐Woo, et al.. (2024). Task-specific facial dystonia following COVID-19 infection: A case report. Medicine. 103(37). e39689–e39689.
3.
Kim, Jae‐Hong, Han‐Gil Jeong, Seung Jae Hyeon, et al.. (2024). Crosstalk between lipocalin-2 and IL-6 in traumatic brain injury: Closely related biomarkers. Experimental Neurology. 385. 115092–115092.
4.
Jeong, Shin Young, et al.. (2024). Deep learning-based binary classification of beta-amyloid plaques using 18F florapronol PET. Nuclear Medicine Communications. 45(12). 1055–1060. 1 indexed citations
5.
Ko, Pan‐Woo, et al.. (2024). A Case of Spinal Muscular Atrophy Type 3a Showing Improvement in Neurofilament Light Chain of Cerebrospinal Fluid: Real-world Evidence. Journal of the Korean Neurological Association. 42(1). 40–43. 1 indexed citations
6.
Ko, Pan‐Woo, Kyunghun Kang, Sang Ryong Kim, et al.. (2021). Human Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Cerebellar Ataxia: A Case Report. Medicina. 57(4). 334–334. 1 indexed citations
7.
Kim, Jong‐Heon, Jong Hyuk Yoon, Sang Ryong Kim, et al.. (2020). Characterization of Mesenchymal Stem Cells Derived from Patients with Cerebellar Ataxia: Downregulation of the Anti-Inflammatory Secretome Profile. Cells. 9(1). 212–212. 12 indexed citations
8.
Nam, Youngpyo, Jong‐Heon Kim, Min Sung Kim, et al.. (2020). Lipopolysaccharide administration for a mouse model of cerebellar ataxia with neuroinflammation. Scientific Reports. 10(1). 13337–13337. 26 indexed citations
10.
Ko, Pan‐Woo, et al.. (2020). Lower Glucose Level Associated With Increased Risk for Post‐Dural Puncture Headache. Headache The Journal of Head and Face Pain. 60(9). 1901–1909. 2 indexed citations
11.
Kim, Jong‐Heon, et al.. (2020). Gliome database: a comprehensive web-based tool to access and analyze glia secretome data. Database. 2020. 5 indexed citations
12.
Ko, Pan‐Woo, Ki‐Su Park, Sung‐Hee Kim, et al.. (2019). Quantitative Gait Analysis and Cerebrospinal Fluid Tap Test for Idiopathic Normal-pressure Hydrocephalus. Scientific Reports. 9(1). 16255–16255. 35 indexed citations
13.
Yoon, Uicheul, et al.. (2018). Amyloid Deposits and Idiopathic Normal-Pressure Hydrocephalus: An <sup>18</sup>F-Florbetaben Study. European Neurology. 79(3-4). 192–199. 4 indexed citations
14.
Ko, Pan‐Woo, Kyunghun Kang, & Ho‐Won Lee. (2018). Levodopa-induced respiratory dysfunction confirmed by levodopa challenge test. Medicine. 97(41). e12488–e12488. 10 indexed citations
15.
Park, Jin‐Sung, Donghwi Park, Pan‐Woo Ko, Kyunghun Kang, & Ho‐Won Lee. (2017). Serum methylmalonic acid correlates with neuropathic pain in idiopathic Parkinson’s disease. Neurological Sciences. 38(10). 1799–1804. 22 indexed citations
16.
Ko, Pan‐Woo, et al.. (2017). Frontal Assessment Battery and Cerebrospinal Fluid Tap Test in Idiopathic Normal-Pressure Hydrocephalus. European Neurology. 77(5-6). 327–332. 11 indexed citations
17.
Lee, Ho‐Won, et al.. (2017). Smart Gait-Aid Glasses for Parkinson's Disease Patients. IEEE Transactions on Biomedical Engineering. 64(10). 2394–2402. 47 indexed citations
18.
Kang, Kyunghun, Pan‐Woo Ko, Myungwon Jin, Kyoungho Suk, & Ho‐Won Lee. (2014). Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test. Journal of Clinical Neuroscience. 21(8). 1398–1403. 38 indexed citations
19.
Ko, Pan‐Woo, Darryl W. Eyles, Alan Mackay‐Sim, et al.. (2005). Report from the Neurology Scientific Integrity Advisor: Year 1. Neurology. 64(7). 1322–1322. 2 indexed citations
20.
Ko, Pan‐Woo, et al.. (1981). Rapid estimation of echocardiographic peak velocity of circumferential fibre shortening (peak Vcf).. Heart. 46(1). 35–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026